Creative Antibiotics AB (OSTO:CAS) EV-to-FCF : 71.93 (As of Jun. 22, 2024)

Creative Antibiotics AB EV-to-FCF Chart

Creative Antibiotics AB Quarterly Data
	Jun08	Mar09	Jun09	Sep09	Dec09	Mar10	Sep10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Mar13
EV-to-FCF	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Creative Antibiotics AB's EV-to-FCF

For the subindustry, Creative Antibiotics AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creative Antibiotics AB's EV-to-FCF Distribution in the Industry

For the industry and sector, Creative Antibiotics AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Creative Antibiotics AB's EV-to-FCF falls into.

Creative Antibiotics AB EV-to-FCF Calculation

Creative Antibiotics AB's EV-to-FCF for today is calculated as:

Creative Antibiotics AB's current Enterprise Value is kr205.86 Mil.
Creative Antibiotics AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Antibiotics AB  (OSTO:CAS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Creative Antibiotics AB's PE Ratio for today is calculated as:

Creative Antibiotics AB's share price for today is kr0.00.
Creative Antibiotics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Creative Antibiotics AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Creative Antibiotics AB (OSTO:CAS) Business Description